3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 性质
| 沸点 | 536.1±40.0 °C(Predicted) |
|---|---|
| 密度 | 1.25±0.1 g/cm3(Predicted) |
| 储存条件 | 2-8°C |
| 溶解度 | 在DMSO中的溶解度为20mg/mL,澄清 |
| 形态 | 粉末 |
| 酸度系数(pKa) | 9.33±0.10(Predicted) |
| 颜色 | 白色至浅棕色 |
| InChI | 1S/C18H20N2O2S/c1-21-12-4-6-16-14(10-12)18(23-9-3-8-19)15-11-13(22-2)5-7-17(15)20-16/h4-7,10-11H,3,8-9,19H2,1-2H3 |
| InChIKey | ZFOMCSNUEHMROO-UHFFFAOYSA-N |
| SMILES | S(CCCN)c1c2c(nc3c1cc(cc3)OC)ccc(c2)OC |
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 用途与合成方法
IC50: 10 nM (Haspin); 48 nM (DYRK2)
LDN-192960 (10 μM) is selective and inhibits ten of the other kinases by ≥90%, with only five being potently inhibited (IC 50 <1 μM), including CLK1 (IC 50 =0.21 μM), DYRK1A (IC 50 = 0.10 μM), DYRK2 (IC 50 =2 nM), DYRK3 (IC 50 =19 nM) and PIM1 (IC 50 =0.72 μM).LDN-0192960 (0-5 μM; 2 hours) demonstrates that the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells overexpressing Haspin with an EC 50 of 1.17 μM.LDN-0192960 (0-1 μM; 1 hour incubation in the presence of nocodazole and MG132) demonstrates the classical Haspin inhibition phenotype by reducing levels of p-Thr3H3 in HeLa cells synchronized in mitosis with an EC 50 of 0.02 μM.
安全信息
| 危险品标志 | Xi |
|---|---|
| 危险类别码 | 36/37/38 |
| 安全说明 | 26 |
| WGK Germany | 3 |
| 海关编码 | 2922290090 |
| 存储类别 | 11 - 可燃固体 |
| 危险性类别 | 眼部刺激 类别2 经皮刺激 类别2 特异性靶器官毒性-一次接触,类别3 |
3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2026-03-03 | S3406 | 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 | 184582-62-5 | 5mg | 2940.21 |
| 2026-03-03 | S3406 | 3-[(2,7-二甲氧基吖啶-9-基)硫基]丙胺 | 184582-62-5 | 25mg | 7944.3 |